First trimester abortion with mifepristone and three doses of sublingual misoprostol: A pilot study

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 45, Issue 6, 2005, Pages 495-498

  Singh, Kishor C ^a   Ummat, Seema ^b   Rajaram, Shalini ^b   Goel, Neerja ^b  

^a FIJI SCHOOL OF MEDICINE   (Fiji)

^b UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

First trimester; Medical abortion; Mifepristone; Misoprostol; Sublingual

Indexed keywords

MIFEPRISTONE; MISOPROSTOL; ROFECOXIB; ABORTIVE AGENT;

ADULT; ANALGESIA; AREA UNDER THE CURVE; ARTICLE; CHILL; CLINICAL ARTICLE; CLINICAL PROTOCOL; DIARRHEA; DISEASE DURATION; DIZZINESS; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; HYPERTHERMIA; MULTIPLE DRUG DOSE; NAUSEA; PAIN ASSESSMENT; PATIENT ATTITUDE; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; THERAPEUTIC ABORTION; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; VAGINA BLEEDING; VISUAL ANALOG SCALE; VOMITING; ADOLESCENT; CONFIDENCE INTERVAL; DOSE RESPONSE; DRUG ADMINISTRATION; INDUCED ABORTION; METHODOLOGY; PREGNANCY; PREGNANCY OUTCOME; PROBABILITY; PROSPECTIVE STUDY; RISK ASSESSMENT; SUBLINGUAL DRUG ADMINISTRATION;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIFEPRISTONE; PILOT PROJECTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 33745000092     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2005.00484.x     Document Type: Article

References (15)

1. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993; 307: 532-537.
2. Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2004: 1: CD002855.
3. Creinin MD, SchwartZ. JL, Pymar HC, Fink W. Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: Report of a randomised trial. Br J Obstet Gynaecol 2001; 108: 469-473.
4. Schaff EA, Fielding SL, Eisinger SH, Stadalius LS, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 2000; 61: 41-46.
5. Tang OS, Shweer H, Seyberth HW et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002; 17: 332-336.
6. Tang OS, Xu J, Cheng L, Lee SW, Ho PC. The effect of contraceptive pills on the measured blood loss in medical termination of pregnancy by mifepristone and misoprostol: A randomized placebo controlled trial. Hum Reprod 2002; 17: 99-102.
7. Tang OS, Gao PP, Cheng L, Lee SW, Ho PC. A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol. Hum Reprod 1999; 14: 722-725.
8. Martin CW, Brown AH, Baird DT. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary. Contraception 1998; 58: 99-103.
9. WHO. Research Group on Post-Ovulatory Methods for Fertility Regulation. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. Br J Obstet Gynaecol. 2003; 110: 808 -818.
10. Creinin MD, Fox MC, Teal S, Chen A, Schaff EA, Meyn LA. MOD Study Trial Group. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol 2004; 103: 851-859.
11. Honkanen H, Piaggio G, Hertzen H et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. Br J Obstet Gynaecol 2004; 111: 715-725.
12. Ho PC, Ngai SW, Liu KL, Wong GCY, Lee SWH. Vaginal misoprostol compared with oral misoprostol in termination of second trimester pregnancy. Obstet Gynaecol 1997; 90: 735-738.
13. Hamoda A, Ashok PW, Dow J et al. A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation. Contraception 2003; 68: 335-338.
14. Tang OS, Chan CC, Lee SW et al. A prospective randomized placebo controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortion of less than 9 weeks. Hum Reprod 2003; 18: 2315-2318.
15. Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM. Factors affecting the outcome of early medical abortion: A review of 4132 consecutive cases. Br J Obstet Gynaecol 2002; 109: 1281-1289.